Halozyme Therapeutics (NASDAQ: HALO)

Biotech

54.48

Avg. Cost

2.47%

Returns

N/A

Investment Score

All content © 2025 North Post Research
Past performance is not a guarantee of futrue results. All investments involve a degree of risk and by using this site, an investor accepts the potential loss of some or all of an investment's value.